RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/39373
https://w3id.org/ripe/ripe-kg/retraction-notice/39373
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
prism:doi |
10.2147/tcrm.s385426 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
prism:publicationDate |
2022-08-10 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
prism:publicationName |
Therapeutics and Clinical Risk Management |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
dcterms:publisher |
ripekg:publisher/RIPEP7DC330A5E3479C06Taylor and Francis - Dove Press |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
dcterms:title |
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
http://purl.org/spar/cito/retracts |
ripekg:work/10.2147%2Ftcrm.s15812 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
rdf:type |
owl:Thing |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
owl:sameAs |
https://semopenalex.org/work/W4294149773 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA02C7C24523188961 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA02C7C24523188961 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripe:concerns |
ripekg:author/RIPEAU6F968D13B49DFACEYoshihiro Sato |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripe:concerns |
ripekg:author/RIPEAU7A6F9D596825D378Jun Iwamoto |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripe:concerns |
ripekg:work/10.2147%2Ftcrm.s15812 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripe:rationale |
Concerns/Issues About Authorship/Affiliation;Concerns/Issues About Data;Duplication of/in Article;Ethical Violations by Author;Falsification/Fabrication of Data;Upgrade/Update of Prior Notice(s) |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripe:retractionWatchRecordId |
39373 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-1-3 |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-inspectai-1-3 |